Join to View Full Profile
67 E 78th StNew York, NY 10075
Phone+1 212-744-2513
Dr. Parikh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Ophthalmology, 2014 - 2017
Vanderbilt University School of MedicineClass of 2013
Certifications & Licensure
MA State Medical License 2018 - 2025
NY State Medical License 2016 - 2025
American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- Anti-VEGF Use for Conditions without US Food and Drug Administration Approval.Ravi Parikh, Elias H Kahan, Casey Zhang, Rhiya Mittal, Arjun Watane
Ophthalmology. Retina. 2025-03-23 - Demographics of Ophthalmology and Optometry Practices and Changes in Utilization Patterns of Procedures and Services Following Private Equity Acquisition.Juliet Del Piero, Sowmya Yennam, Anirudh Mukhopadhyay, Evan M Chen, Christina Y Weng
International Ophthalmology Clinics. 2025-01-01 - Reply to Comment On: Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study.Karen M Wai, Kapil Mishra, Euna Koo, Cassie Ann Ludwig, Ravi Parikh
American Journal of Ophthalmology. 2024-12-01
Press Mentions
Slow Start for AI-Assisted Screening for Diabetic Retinopathy Despite PromiseNovember 8th, 2024- Approval of Bevacizumab Biosimilar for Ophthalmic Use Could Upend Low-Cost Anti-VEGFOctober 24th, 2024
- Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual MeetingMay 29th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
